A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

Name: A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
License: Public Domain

OncoNano Medicine, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

non

triple negative breast cancer, diffuse large b cell lymphoma, follicular lymphoma, lymphoma, non-hodgkin, mantle cell lymphoma, bladder cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 349949
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.